BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260603T075653EDT-5431zhpOKz@132.216.98.100
DTSTAMP:20260603T115653Z
DESCRIPTION:Le Groupe de recherche en santé et droit de 91������ vous invite 
 à son troisième séminaire de l'année universitaire\, présenté par le profe
 sseur Yann Joly\, DCL'09\, directeur de recherche du Centre de génomique e
 t de politique (CGP) et professeur agrégé à la Faculté de médecine de l'Un
 iversité 91������. Il nous parlera des défis auxquelles les personnes inters
 exuées sont confrontées en matière d'accès aux soins de santé.\n\nLes plac
 es sont limitées. Prière de confirmer sa présence auprès de rghl.law [at] 
 mcgill.ca.\n\nCette activité est admissible pour 1\,5 heures de formation 
 continue obligatoire tel que déclaré par les membres du Barreau du Québec.
 \n\nRésumé\n\n[En anglais seulement] About 1.7% of the Canadian population
  falls under the umbrella of “intersex”\, including sexual variation at th
 e chromosomal\, gonadal\, hormonal\, and genital levels. For intersex pati
 ents\, healthcare is fraught with difficulties due to the various harms th
 ey suffer\, including the concealment of medical information and trauma du
 e to non-consensual pediatric surgical procedures.\n\nIn June 2017\, three
  former US Surgeon Generals published a policy brief recognizing the psych
 osocial harms caused by the stigmatization of intersex individuals. Furthe
 rmore\, in October 2017\, the Parliamentary Assembly of the Council of Eur
 ope called for a ban on medically unnecessary 'sex-normalizing' surgical i
 nterventions on intersex children. Unfortunately\, intersex individuals st
 ill face serious human rights violations\, discrimination\, and stigmatiza
 tion. Qualitative research\, on which best practices and medical policies 
 can be based to prevent these prejudices\, remains underdeveloped. Additio
 nally\, there is presently a lack of Canadian-specific guidance or explici
 t legal protections to guide healthcare providers in their relationship wi
 th intersex patients.\n\nThis seminar will present the development of our 
 project on access to healthcare for the intersex population in Québec and 
 Canada\, focusing on the following aspects: 1) presentation of the main ob
 jectives of the project\; 2) challenges posed by research with the interse
 x community\; 3) identification of foreign laws and policies of interest f
 or the Canadian context\; and 4) a description of the next steps to enable
  the development of public policies allowing better access to healthcare f
 or this marginalized population.\n\nLe conférencier\n\n[En anglais seuleme
 nt] Yann Joly\, Ph.D. (DCL)\, FCAHS\, Ad.E.\, is the Research Director of 
 the Centre of Genomics and Policy (CGP)\, located inside the Genome Quebec
  Innovation Centre at 91������. He is also an Associate Professor
  at the Faculty of Medicine\, Department of Human Genetics cross-appointed
  at the Bioethics Unit\, at 91������. Professor Joly is a member 
 of the Canadian Commission for UNESCO (CCU) Sectoral Commission for Natura
 l\, Social and Human Sciences. He is the current Chair of the Bioethics Wo
 rkgroup of the International Human Epigenome Consortium (IHEC)\, and of th
 e Ethics and Governance Committee of the International Cancer Genome Conso
 rtium (ICGC). He is also a member of the Human Genome Organization (HUGO) 
 Committee on Ethics\, Law and Society (CELS). Professor Joly’s research in
 terests lie at the interface of the fields of scientific knowledge\, healt
 h law (biotechnology and other emerging health technologies) and bioethics
 .\n
DTSTART:20200109T210000Z
DTEND:20200109T223000Z
LOCATION:Stephen Scott Seminar Room (OCDH 16)\, Chancellor Day Hall\, CA\, 
 QC\, Montreal\, H3A 1W9\, 3644 rue Peel
SUMMARY:The Challenges in Access to Healthcare for Intersex Individuals
URL:/law/fr/channels/event/challenges-access-healthcar
 e-intersex-individuals-303385
END:VEVENT
END:VCALENDAR